BioLargo Inc BLGO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY
-
BioLargo to Host Ribbon-Cutting Event for Battery Pilot Manufacturing Facility
-
Clyra Medical Technologies, a Subsidiary of BioLargo, Appoints Dr. Steven J. Kavros as Chief Medical Officer
-
Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY
-
BioLargo Earnings Results Webcast and Conference Call on Wednesday, August 14, 2024 - 1:30 PM Pacific Time
-
BioLargo Achieves Record Quarterly Revenue of $5 Million for Second Quarter of 2024
Trading Information
- Previous Close Price
- $0.24
- Day Range
- $0.24–0.25
- 52-Week Range
- $0.16–0.45
- Bid/Ask
- $0.24 / $0.25
- Market Cap
- $73.35 Mil
- Volume/Avg
- 108,569 / 154,157
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.18
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
BioLargo Inc invents, develops, and commercializes platform technologies to solve challenging environmental problems like PFAS contamination, water, and wastewater treatment, industrial odor, and VOC control, air quality control, and infection control. The company has five segments: ONM Environmental; Clyra Medical; BLEST; BioLargo Canada and BioLargo corporate. ONM Environmental which sells odor and volatile organic control products and services, located in Westminster, California derives the maximum revenue.
- Sector
- Basic Materials
- Industry
- Chemicals
- Stock Style Box
- Small Core
- Total Number of Employees
- 33
- Website
- https://www.biolargo.com
Comparables
Valuation
|
Metric
|
BLGO
|
CLH
|
688370
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 37.18 | 70.68 |
Price/Book Value | 11.95 | 5.43 | 0.85 |
Price/Sales | 4.18 | 2.37 | 3.84 |
Price/Cash Flow | — | 16.08 | 13.33 |
Price/Earnings
BLGO
CLH
688370
Financial Strength
|
Metric
|
BLGO
|
CLH
|
688370
|
|---|---|---|---|
Quick Ratio | 2.28 | 1.67 | 3.51 |
Current Ratio | 2.36 | 2.10 | 3.69 |
Interest Coverage | −89.73 | 4.68 | 2.51 |
Quick Ratio
BLGO
CLH
688370
Profitability
|
Metric
|
BLGO
|
CLH
|
688370
|
|---|---|---|---|
Return on Assets (Normalized) | −13.69% | 6.28% | 0.49% |
Return on Equity (Normalized) | −15.98% | 18.24% | 0.63% |
Return on Invested Capital (Normalized) | −17.56% | 10.18% | 0.94% |
Return on Assets
BLGO
CLH
688370
Chemicals Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Shin-Etsu Chemical Co Ltd DR
SHECY
| — | Hmbps | $81.8 Bil | |||
| Shin-Etsu Chemical Co Ltd
SHECF
| — | Bmdscvj | $81.8 Bil | |||
| Basf SE
BFFAF
| — | Dfdrj | $45.3 Bil | |||
| Basf SE ADR
BASFY
| Wvsmnqwz | Tvfvj | $45.3 Bil | |||
| Dow Inc
DOW
| Flqhrmkv | Gwsfz | $37.0 Bil | |||
| Nippon Sanso Holdings Corp
TYNPF
| — | Nrkhbgx | $16.1 Bil | |||
| Celanese Corp Class A
CE
| Bfskpdgxn | Ycmqvq | $14.2 Bil | |||
| Asahi Kasei Corp ADR
AHKSY
| — | Yprj | $10.5 Bil | |||
| Asahi Kasei Corp
AHKSF
| — | Mly | $10.5 Bil | |||
| Ganfeng Lithium Group Co Ltd ADR
GNENY
| — | Srwwqz | $7.3 Bil |
United States